FAP and neoplasm: However, the novel cyclic peptide-based FAP analogue, FAP-2286, showed a significantly slower clearance from the stroma of the tumor tissue, as seen in xenografted SCID beige mice, when radiolabeled with lutetium-177 compared to [177Lu]Lu-FAPI-46 [11].